Related Experiment Video

Updated: Jun 13, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
07:48

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia

Published on: June 8, 2019

Therapeutic angiogenesis for the management of refractory angina: current concepts

Steve Attanasio1, Gary Schaer

  • 1Section of Adult Cardiology, Rush University Medical Center, 1653 West Congress Parkway, Chicago, IL 60612, USA. steve_attanasio@rush.edu

Cardiovascular Therapeutics
|April 22, 2010
PubMed

Insights

Therapeutic angiogenesis offers a new treatment for patients with refractory coronary artery disease (CAD) who have angina despite standard therapies. This approach aims to create new blood vessels, potentially improving blood flow and easing symptoms for "no-option" patients.

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Molecular Cardiology

Background:

  • Coronary artery disease (CAD) management aims to reduce ischemia, prevent cardiac events, and relieve angina.
  • Conventional medical and mechanical therapies are effective but leave some patients with refractory angina.
  • A subset of CAD patients remains symptomatic despite maximal treatment, termed "no-option" patients.

Purpose of the Study:

  • To review the current status of therapeutic angiogenesis for "no-option" patients with refractory angina.
  • To explore the potential of gene, protein, and cell-based therapies in inducing new blood vessel formation.
  • To assess the clinical benefit and future prospects of therapeutic angiogenesis in ischemic heart disease.

Main Methods:

  • Review of existing literature on therapeutic angiogenesis in CAD.
  • Analysis of studies employing gene, protein, and cell-based approaches.
  • Focus on outcomes related to angina relief and improved myocardial perfusion.

Main Results:

  • Therapeutic angiogenesis aims to restore blood flow by forming new vessels in ischemic areas.
  • Evidence suggests a potential clinical benefit for patients with refractory angina.
  • Gene, protein, and cell-based therapies are being investigated for their angiogenic potential.

Conclusions:

  • Therapeutic angiogenesis presents a promising novel treatment strategy for "no-option" patients with refractory angina.
  • While not definitive, current data indicate a positive trend and warrant optimism.
  • Further research is essential to solidify the role of therapeutic angiogenesis in managing severe CAD.

More Related Videos

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging10:50

Osmotic Drug Delivery to Ischemic Hindlimbs and Perfusion of Vasculature with Microfil for Micro-Computed Tomography Imaging

Published on: June 29, 2013

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...